Stevanato Group S.p.A. (STVN)
NYSE·Healthcare·Medical - Instruments & Supplies
$16.03
-0.93%
Mkt Cap $4.42B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $391.27M | $406.97M | +4.01% | $0.20 | $0.21 | +5.00% | — | — |
| Q4 2025 Nov 6, 2025 | $385.49M | $355.08M | -7.89% | $0.14 | $0.16 | +14.29% | — | — |
| Q3 2025 Aug 5, 2025 | $343.21M | $329.73M | -3.93% | $0.11 | $0.12 | +9.09% | — | — |
| Q2 2025 May 8, 2025 | $301.60M | $281.29M | -6.73% | $0.10 | $0.11 | +10.00% | — | — |
| Q1 2025 Mar 6, 2025 | $268.16M | $342.33M | +27.66% | $0.20 | $0.20 | +0.00% | — | — |
| Q4 2024 Nov 5, 2024 | $345.14M | $304.75M | -11.70% | $0.14 | $0.13 | -7.68% | — | — |
| Q3 2024 Aug 6, 2024 | $325.38M | $279.11M | -14.22% | $0.11 | $0.10 | -9.98% | — | — |
| Q2 2024 May 9, 2024 | $300.51M | $253.52M | -15.64% | $0.12 | $0.09 | -27.28% | — | — |
| Q1 2024 Mar 7, 2024 | $284.25M | $352.63M | +24.05% | $0.21 | $0.20 | -5.25% | — | — |
| Q4 2023 Oct 31, 2023 | $384.09M | $286.30M | -25.46% | $0.16 | $0.16 | +0.00% | — | — |
| Q3 2023 Jul 28, 2023 | $336.03M | $278.51M | -17.12% | $0.14 | $0.15 | +7.68% | — | — |
| Q2 2023 May 4, 2023 | $296.79M | $258.75M | -12.82% | $0.13 | $0.12 | -8.32% | — | — |
| Q1 2023 Mar 2, 2023 | $275.33M | $314.64M | +14.28% | $0.17 | $0.19 | +12.52% | — | — |
| Q4 2022 Nov 8, 2022 | $240.79M | $239.52M | -0.53% | $0.13 | $0.14 | +7.67% | — | — |
| Q3 2022 Aug 4, 2022 | $239.50M | $245.03M | +2.31% | $0.12 | $0.12 | +0.00% | — | — |
| Q2 2022 May 10, 2022 | $234.84M | $234.58M | -0.11% | $0.10 | $0.11 | +9.96% | — | — |
| Q1 2022 Mar 8, 2022 | $250.71M | $263.67M | +5.17% | $0.11 | $0.14 | +29.99% | — | — |
| Q4 2021 Nov 9, 2021 | $239.28M | $249.01M | +4.07% | $0.11 | $0.12 | +9.09% | — | — |
| Q3 2021 Aug 19, 2021 | $239.28M | $241.99M | +1.13% | $0.18 | $0.16 | -6.66% | — | — |
| Q1 2021 Mar 31, 2021 | — | $226.83M | — | — | $0.14 | — | — | — |